Clinical trial · Observational
Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria
BreCaReAl: Breast Cancers Registry in Algeria
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
National, prospective, multicentre, non-interventional epidemiological study, conducted among oncologists and breast surgeons in community and university hospitals, from the public sector in Algeria. The study will collect information on the characteristics, and breast carcinomas patterns of patients whose breast cancer diagnosis was confirmed by an anatomopathologist. The study will be conducted over a representative, but not exhaustive sample of Algerian female patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Epidemiology | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| NIS (Non Interventional Study) observational study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Breast Cancer Patients
- description
- Newly diagnosed with breast cancer all stages confirmed during the study period by an anatomopathologist, defined as a first diagnosis of breast cancer based on anatomopathological results from at least a microbiopsy
- interventionNames
- Other: NIS (Non Interventional Study) observational study
Primary outcomes (1)
- measure
- Survival status at 05 years (percentage of patients still alive at 05 years)
- timeFrame
- 60 months
- description
- Survival status at 60 months based on the percentage of patients still alive at 05 years
Secondary outcomes (3)
- measure
- incidence all cases
- timeFrame
- 06 months
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: Patients will be eligible to participate to the study if they fulfil all of the following criteria: * Female patients * Aged 18 years and over * Newly diagnosed with breast cancer all stages confirmed during the study period by an anatomopathologist, defined as a first diagnosis of breast cancer based on anatomopathological results from at least a microbiopsy * Provision of subject informed consent. Exclusion Criteria: Patients will not be eligible to participate if any of the following criteria are present: * Informed consent not obtained. * Patients with a mental or psychological disorder according to their treating clinicians * Patients participating in an interventional study or already included in the study. A patient could be consulted and treated in two different centres, thus a codification system will be generated to avoid duplicate participation
References
Publications (0)
Data not yet available